To see if Remdesivir, an antiviral drug helped in reducing the hospital stay and helped patients with COVID 19infection recover faster?

Not yet recruiting

• Conditions: Coronavirus as the cause of diseases classified elsewhere, (2) ICD-10 Condition: J128||Other viral pneumonia,

• Registration Number: CTRI/2021/04/032904
• Lead Sponsor: Dr Punam Bhende

Brief Summary

This is an observational study, wherein we will go through records of patients admitted with moderate and severe COVID infection in our hospital and received remdesivir ,during the period specified. Comorbidities, age, duration of symptom onset and presentation to the hospital will be noted. Hospital stay, outcome- discharge/ death/ duration of oxygen requirement will also be studied.

This is to see the clinical outcomes in patients receiving Remdesivir.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-04-16
• Study Start: 2021-04-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

Not Applicable.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death, Discharge, Length of stay in hospital, duration of O2therapy	3 months

Secondary Outcome Measures

Name	Time	Method
the results will help in decision making and add to existing treatment protocols	3 months

Trial Locations

Locations (1)

Shree Krishna Hospital; 🇮🇳 Anand, GUJARAT, India

Shree Krishna Hospital

🇮🇳Anand, GUJARAT, India

Dr Punam Bhende

Principal investigator

9480703214

punamvb@charutarhealth.org